Status:
COMPLETED
Smoking, Sex Hormones, and Pregnancy
Lead Sponsor:
University of Minnesota
Conditions:
Nicotine Dependence
Contraception
Eligibility:
FEMALE
18-35 years
Phase:
PHASE2
Brief Summary
The investigators aim to (1) examine the association between levels of progesterone (Prog), allopregnanolone (Allo), and the estradiol/progesterone (E2/P) ratios with smoking-related symptomatology du...
Detailed Description
The sample population will consist of oral contraceptive users, both "low" and "high" dose levels of exogenous progesterone with a consistent dose of exogenous estrogen. Participants will complete dat...
Eligibility Criteria
Inclusion
- currently taking oral contraceptives
- English fluency
- Ability to provide informed consent
Exclusion
- use of progestin only contraceptive
- pregnancy
Key Trial Info
Start Date :
December 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2017
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT01811225
Start Date
December 1 2012
End Date
June 1 2017
Last Update
November 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Masonic Cancer Center, University of Minnesota
Minneapolis, Minnesota, United States, 55455